Amplifiers

A New Testing Strategy: High Value PCR Screening Delivers Rapid Results for Legionella Detection in Building Water Systems

Retrieved on: 
Tuesday, March 10, 2020

High Value PCR Screening enables Water Management Teams to solve problems faster, and more defensibly, which drives time and resource savings.

Key Points: 
  • High Value PCR Screening enables Water Management Teams to solve problems faster, and more defensibly, which drives time and resource savings.
  • The High Value PCR Screening strategy implements the speed and accuracy of the Phigenics Next Day PCR (a molecular method for detection of Legionella DNA in water samples) to rapidly profile an entire building water system.
  • Those interested in learning more about the High Value PCR Screening strategy can visit: https://info.phigenics.com/testing
    Phigenics sells comprehensive water management programs .
  • These programs include regulatory compliance, data management and water testing analytical services, including Legionella testing services.

Lumentum Introduces Revolutionary High-Power Pump Lasers

Retrieved on: 
Tuesday, March 10, 2020

SAN JOSE, Calif., March 10, 2020 /PRNewswire/ --Lumentum Holdings Inc. ("Lumentum") today announced a breakthrough series of advanced 980 nanometer (nm) single-mode pump lasers, adding to its already broad family of pump lasers for optical amplification.

Key Points: 
  • SAN JOSE, Calif., March 10, 2020 /PRNewswire/ --Lumentum Holdings Inc. ("Lumentum") today announced a breakthrough series of advanced 980 nanometer (nm) single-mode pump lasers, adding to its already broad family of pump lasers for optical amplification.
  • The new 980 nm pump lasers offer significantly higher power and higher efficiency, enabling high-density erbium-doped fiber amplifier (EDFA) designs.
  • The pump lasers employ revolutionary chips that are based on Lumentum's field-proven, proprietary, high-reliability technology, but offer operating power levels from 250 mW to 1600 mW.
  • "Lumentum is supporting the industry's need for ultra-high reliability, high-power, and scalable pump lasers for pluggable EDFAs," said Doug Alteen, Senior Vice President, General Manager, Telecom Transport.

Global Isothermal Nucleic Acid Amplification Technology Market Analysis, Trends, and Forecasts 2019-2025 - ResearchAndMarkets.com

Retrieved on: 
Monday, March 9, 2020

The "Isothermal Nucleic Acid Amplification Technology (INAAT) - Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Isothermal Nucleic Acid Amplification Technology (INAAT) - Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering.
  • Isothermal Nucleic Acid Amplification Technology (INAAT) market worldwide is projected to grow by US$2.2 Billion, driven by a compounded growth of 11.5%.
  • Infectious Diseases, one of the segments analyzed and sized in this study, displays the potential to grow at over 12.2%.
  • Poised to reach over US$2.6 Billion by the year 2025, Infectious Diseases will bring in healthy gains adding significant momentum to global growth.

German Lab Demonstrates Feasibility to Detect SARS-Coronavirus-2 (SARS-CoV-2) Using Hologic’s Panther Fusion® System

Retrieved on: 
Thursday, March 5, 2020

Using inactivated virus from cell cultures and commercially available control materials, we adapted two recently published PCR protocols2 to run on the Panther Fusion system.

Key Points: 
  • Using inactivated virus from cell cultures and commercially available control materials, we adapted two recently published PCR protocols2 to run on the Panther Fusion system.
  • We specifically designed Panther Fusion and Open Access functionality to give diagnostic lab customers maximum flexibility, both for their day-to-day needs and to respond quickly to emerging threats.
  • Specifically, the Panther Fusion module adds the capacity to run PCR assays and the Open Access functionality allows labs to develop LDTs using the platform.
  • Hologic, Panther, Panther Fusion, and Open Access are trademarks and/or registered trademarks of Hologic, Inc. in the United States and/or other countries.

COVID-19 Could Be Identified in Minutes via Mobile Technology

Retrieved on: 
Monday, March 2, 2020

Initial testing of the Liberty16 using COVID-19 sequences validated by the US CDC and approved by the US FDA for COVID-19 testing has been positive.

Key Points: 
  • Initial testing of the Liberty16 using COVID-19 sequences validated by the US CDC and approved by the US FDA for COVID-19 testing has been positive.
  • Ubiquitome received a last-minute request to speak at the 27th International Molecular Medicine Tri-Conference in San Francisco March 1 4.
  • The conference focuses on emerging therapeutic, diagnostic and technology approaches to advance precision medicine, digital health and Bio-IT.
  • The Liberty 16 performed the same as the large laboratory-scale, real-time PCR machines currently being used to test for COVID-19.

Global PCR System for Food Diagnostics Market Projected to Grow in Value to USD 833.14 Million by 2024 with a CAGR of 8% - ResearchAndMarkets.com

Retrieved on: 
Friday, February 28, 2020

The "Global PCR System for Food Diagnostics Market 2020-2024" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global PCR System for Food Diagnostics Market 2020-2024" report has been added to ResearchAndMarkets.com's offering.
  • The publisher has been monitoring the global pcr system for food diagnostics market and it is poised to grow by USD 833.14 mn during 2020-2024, progressing at a CAGR of 8% during the forecast period.
  • The market is driven by rising foodborne illnesses.In addition, advances in pcr system is anticipated to boost the growth of the global pcr system for food diagnostics market as well.
  • This study identifies advances in pcr system as the prime reasons driving the global pcr system for food diagnostics market growth during the next few years.

The Global PCR System for Food Diagnostics Market is expected to grow by USD 833.14 mn during 2020-2024, progressing at a CAGR of 8% during the forecast period

Retrieved on: 
Monday, February 24, 2020

This study identifies advances in pcr system as the prime reasons driving the global pcr system for food diagnostics market growth during the next few years.

Key Points: 
  • This study identifies advances in pcr system as the prime reasons driving the global pcr system for food diagnostics market growth during the next few years.
  • The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry.
  • The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
  • Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

Molecular Biology Systems and Velocidy Bio sign distribution agreement NEXTGENPCR, the ultrafast PCR system, is now available in the United States and Canada

Retrieved on: 
Wednesday, February 19, 2020

FREDERICK, Md., Feb. 19, 2020 /PRNewswire-PRWeb/ -- Molecular Biology Systems (MBS), the developer of NEXTGENPCR, is pleased to announce their newest distributor, Velocidy Bio.

Key Points: 
  • FREDERICK, Md., Feb. 19, 2020 /PRNewswire-PRWeb/ -- Molecular Biology Systems (MBS), the developer of NEXTGENPCR, is pleased to announce their newest distributor, Velocidy Bio.
  • Velocidy Bio becomes the exclusive distributor of NEXTGENPCR instruments, accessories and consumables in the United States and Canada.
  • The NEXTENPCR instrument, accessories, and consumables are now available in the United States and Canada for purchase through Velocidy Bio at http://www.velocidybio.com .
  • For other countries, please see Molecular Biology Systems' commercial partners at http://www.nextgenpcr.com/buy-nextgen-pcr/
    Molecular Biology Systems B.V. is a Netherlands company that developed and commercialized NEXTGENPCR, a universal ultrafast PCR system.

Global Molecular Diagnostics Market (2019 to 2026) - Featuring Abbott Laboratories, Biomrieux, Danaher Corporation & Exact Sciences Corporation Among Others - ResearchAndMarkets.com

Retrieved on: 
Thursday, February 13, 2020

According to the publisher's analysis, the molecular diagnostics global market is estimated to reach $18,668.9 million by 2026 growing at a high single-digit CAGR from 2019 to 2026.

Key Points: 
  • According to the publisher's analysis, the molecular diagnostics global market is estimated to reach $18,668.9 million by 2026 growing at a high single-digit CAGR from 2019 to 2026.
  • The molecular diagnostics global market is a competitive market and all the existing players in this market are involved in developing new and advanced molecular based techniques for diagnosis to maintain their market shares and also acquiring companies for product expansion.
  • The molecular diagnostics global market is segmented based on product, technology, application and end-users.
  • The molecular diagnostics global market by technology is divided into PCR, microarray and microfluidics, isothermal nucleic acid amplification tests, in-situ hybridization, NGS and other technologies.

Scientists from Noblis and Defense Biological Product Assurance Office (DBPAO) Identify Unique Genetic Sequences of the International Wuhan Coronavirus

Retrieved on: 
Wednesday, February 12, 2020

RESTON, Va., Feb. 12, 2020 /PRNewswire-PRWeb/ --Scientists from Noblis and the Defense Biological Product Assurance Office (DBPAO), a component of the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND), are continuously evaluating polymerase chain reaction (PCR) assays (tests) for detection of the new Wuhan coronavirus.

Key Points: 
  • RESTON, Va., Feb. 12, 2020 /PRNewswire-PRWeb/ --Scientists from Noblis and the Defense Biological Product Assurance Office (DBPAO), a component of the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND), are continuously evaluating polymerase chain reaction (PCR) assays (tests) for detection of the new Wuhan coronavirus.
  • "Noblis is pleased to collaborate with our customers to accelerate the virus detection process and combat the coronavirus outbreak," said Amr ElSawy, president and CEO, Noblis.
  • The research was done using BioLaboro, a Noblis application developed for rapidly designing de novo (new) assays and validating existing PCR detection assays.
  • The four Noblis assays were found to be in different locations in the genome sequence compared to the other assays.